194 related articles for article (PubMed ID: 9401937)
21. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
22. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
23. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies.
Maher S; Wang X; Bzik V; McClean S; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):301-11. PubMed ID: 19664704
[TBL] [Abstract][Full Text] [Related]
25. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
26. In vitro interactions between the oral absorption promoter, sodium caprate (C(10)) and S. typhimurium in rat intestinal ileal mucosae.
Cox AB; Rawlinson LA; Baird AW; Bzik V; Brayden DJ
Pharm Res; 2008 Jan; 25(1):114-22. PubMed ID: 17546408
[TBL] [Abstract][Full Text] [Related]
27. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.
Pan W; Banks WA; Kastin AJ
Exp Neurol; 1997 Aug; 146(2):367-73. PubMed ID: 9270046
[TBL] [Abstract][Full Text] [Related]
28. Absorption-enhancing effects of sodium caprate and palmitoyl carnitine in rat and human colons.
Shimazaki T; Tomita M; Sadahiro S; Hayashi M; Awazu S
Dig Dis Sci; 1998 Mar; 43(3):641-5. PubMed ID: 9539662
[TBL] [Abstract][Full Text] [Related]
29. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
[TBL] [Abstract][Full Text] [Related]
30. Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat.
Söderholm JD; Oman H; Blomquist L; Veen J; Lindmark T; Olaison G
Dig Dis Sci; 1998 Jul; 43(7):1547-52. PubMed ID: 9690393
[TBL] [Abstract][Full Text] [Related]
31. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
32. Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker
Dahlgren D; Roos C; Lundqvist A; Tannergren C; Langguth P; Sjöblom M; Sjögren E; Lennernäs H
Mol Pharm; 2017 Dec; 14(12):4243-4251. PubMed ID: 28737406
[TBL] [Abstract][Full Text] [Related]
33. Differences in the enhancing effects of sodium caprate on colonic and jejunal drug absorption.
Tomita M; Sawada T; Ogawa T; Ouchi H; Hayashi M; Awazu S
Pharm Res; 1992 May; 9(5):648-53. PubMed ID: 1608897
[TBL] [Abstract][Full Text] [Related]
34. Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.
Stuettgen V; Brayden DJ
AAPS J; 2020 Jan; 22(2):33. PubMed ID: 31989362
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.
Yamamoto A; Uchiyama T; Nishikawa R; Fujita T; Muranishi S
J Pharm Pharmacol; 1996 Dec; 48(12):1285-9. PubMed ID: 9004192
[TBL] [Abstract][Full Text] [Related]
36. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
Sugiyama T; Yamamoto A; Kawabe Y; Uchiyama T; Quan YS; Muranishi S
Biol Pharm Bull; 1997 Jul; 20(7):812-4. PubMed ID: 9255426
[TBL] [Abstract][Full Text] [Related]
37. Brain transfer of a new neuromodulating ACTH analog, ebiratide, in rats.
Shimura T; Tabata S; Hayashi S
Peptides; 1991; 12(3):509-12. PubMed ID: 1681522
[TBL] [Abstract][Full Text] [Related]
38. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
40. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
